RT Journal Article
SR Electronic
T1 Double Mammary In Situ: Predicting Feasibility of Right Mammary Artery In Situ for Circumflex Coronary Artery System
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.05.20243964
DO 10.1101/2020.12.05.20243964
A1 Margaryan, Rafik
A1 Latta, Daniele Della
A1 Bianchi, Giacomo
A1 Martini, Nicola
A1 Gori, Andrea
A1 Solinas, Marco
YR 2021
UL http://medrxiv.org/content/early/2021/09/04/2020.12.05.20243964.abstract
AB Objectives Double (bilateral) mammary artery in situ revascularization seems less attractive to surgeons because of limited mammary length of right mammary artery, scare, or no means of its length estimation.Methods We’ve selected patients who have used bilateral mammary artery for revascularization and divvied them into two groups: in situ and y-graft groups. We have used preoperative chest x-rays to build a predictive model with neural networks that could predict feasibility of in situ bilateral mammary revascularization.Results The predictive model was able to predict a positive outcome with 96% percent accuracy (p < 0.01). Models sensitivity and specificity were 96% and 95% respectively. Neural networks can be used to predict double mammary feasibility using chest x-rays. Model is capable of predicting positive outcomes with 95% accuracy.Conclusions Chest x-ray base model can accurately predict the feasibility of in situ bilateral mammary artery revascularization.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding involved.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Review Board of Fondazione G Monasterio Massa Italy granted ethical approval to this study in February 2020.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data will be available after deidentification.